Angelis, A;
Naci, H;
Hackshaw, A;
(2020)
Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies.
Pharmacoeconomics
, 38
pp. 1297-1308.
10.1007/s40273-020-00956-w.
Preview |
Text
Hackshaw_Manuscript_Cell and gene therapies_PCE_16JUL2020_Clean.pdf - Accepted Version Download (920kB) | Preview |
Abstract
Recently licensed cell and gene therapies have promising but highly uncertain clinical benefits. They are entering the market at very high prices, with the latest entrants costing hundreds of thousands of dollars. The significant long-term uncertainty posed by these therapies has already complicated the use of conventional economic evaluation approaches such as cost-effectiveness and cost-utility analyses, which are widely used for assessing the value of new health interventions. Cell and gene therapies also risk jeopardising healthcare systems' financial sustainability. As a result, there is a need to recalibrate the current health technology assessment methods used to measure and compensate their value. In this paper, we outline a set of technical adaptations and methodological refinements to address key challenges in the appraisal of cell and gene therapies' value, including the assessment of efficiency and affordability. We also discuss the potential role of alternative financing mechanisms. Ultimately, uncertainties associated with cell and gene therapies can only be meaningfully addressed by improving the evidence base supporting their approval and adoption in healthcare systems.
Type: | Article |
---|---|
Title: | Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies |
Location: | New Zealand |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1007/s40273-020-00956-w |
Publisher version: | http://dx.doi.org/10.1007/s40273-020-00956-w |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > CRUK Cancer Trials Centre |
URI: | https://discovery.ucl.ac.uk/id/eprint/10110965 |
Archive Staff Only
![]() |
View Item |